Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M280,494Revenue $M74,331Net Margin (%)21.6Altman Z-Score5.3
Enterprise Value $M268,158EPS $5.7Operating Margin %28.1Piotroski F-Score6
P/E(ttm)18.3Beneish M-Score-2.6Pre-tax Margin (%)28.2Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %4.3Quick Ratio2.1Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %3.5Current Ratio2.4Lower Leverage y-yN
Price/Free Cash Flow21.2y-y EBITDA Growth Rate %16.9ROA % (ttm)12.1Higher Current Ratio y-yY
Dividend Yield %2.8PEG5.2ROE % (ttm)21.6Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M2,773ROIC % (ttm)27.1Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stoffels PaulusChief Scientific Officer 2015-04-28Sell187,250$100.730.4view
Fasolo PeterVP, Global Human Resources 2015-03-05Sell115,307$102.4-1.24view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.55-6.84view
Ullmann Michael HVP, General Counsel 2014-10-31Sell17,350$107.43-5.86view
CULLEN JAMESDirector 2014-09-10Sell2,446$104.12-2.87view
Caruso Dominic JVP, Finance; CFO 2014-08-21Sell30,000$104.3-3.04view
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.051.08view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.158.57view
COSGROVE STEPHEN JCorporate Controller 2013-08-14Sell17,200$91.3910.66view
Ullmann Michael HVP, General Counsel 2013-08-05Sell16,140$93.687.95view

Press Releases about JNJ :

    Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    11 Reasons to be a Dividend Growth Investor May 27 2015 
    Big Pharma Companies Are Betting On Regenerative Medicine - Should You? May 26 2015 
    Johnson & Johnson Drug Pipeline to Help it Deliver Above-Average Growth May 22 2015 
    UBS and JMP Securities Downgrade Achillion Pharmaceuticals Inc.(ACHN) Following Johnson & Johnson (J May 21 2015 
    International Diversification May Be Closer than You Think May 20 2015 
    Dycom Industries (DY) Surpasses Estimates; Achillion Pharma (ACHN) Inks Mega-Deal with Janssen May 20 2015 
    Sector Allocation As It Pertains To Dividend Growth Investing May 19 2015 
    Ken Fisher Adds to His Johnson and Johnson Position May 16 2015 
    Johnson & Johnson A Good Investment Despite Current Lows May 14 2015 
    10 Small/Mid-Cap Dividend Growth Stocks Answering The Call May 13 2015 

    More From Other Websites
    FBI Is Investigating Hysterectomy Device Found to Spread Uterine Cancer May 27 2015
    Johnson & Johnson's 3 Most Important Numbers May 27 2015
    FBI probing what J&J knew about uterine surgery device - WSJ May 27 2015
    FBI probing what J&J knew about uterine surgery device - WSJ May 27 2015
    FBI probing what J&J knew about uterine surgery device - WSJ May 27 2015
    US not thinking about extending nuclear talks May 27 2015
    Utah defends contentious law on contact lens price-fixing May 27 2015
    Utah defends contentious law on contact lens price-fixing May 27 2015
    How Law Firms Use Facebook and Other Data to Track Down Medical Victims May 27 2015
    3 High-Yield, Low-Risk Dividend Stocks for Extreme Safety May 27 2015
    How to Use Options to Profit From Johnson & Johnson's Success May 27 2015
    Johnson & Johnson to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference May 27 2015
    Johnson & Johnson to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference May 27 2015
    Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck May 26 2015
    Cramer: I'm Buying J&J as It Has the Most Upside of Major Pharmas May 26 2015
    SIMPONI® Receives CHMP Positive Opinion for Treatment of Non-Radiographic Axial Spondyloarthritis... May 26 2015
    The Zacks Analyst Blog Highlights: Johnson & Johnson, AstraZeneca, ACADIA Pharmaceuticals, Actavis... May 26 2015
    Pharma Trumps All Healthcare Sectors In Executive Compensation May 26 2015
    Considering the Investment Impact of Baby Boomers’ Retirement May 25 2015
    Johnson & Johnson Seeks to Deliver 10 Blockbusters May 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Gurufocus
    ReplyGurufocus - 1 year ago
    test
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK